Reid Hoffman/Form 4 reports 98,387 VOR shares sold, 1.50M held
Rhea-AI Filing Summary
Vor Biopharma Inc. reporting persons Reprogrammed Interchange LLC and Reid Hoffman disclosed multiple open-market sales of common stock on 10/06/2025 and 10/07/2025. The filings show four sale lines: 17,760 shares at a weighted average price of $36.0018, 34,847 shares at $37.1213, 18,156 shares at $37.7743, and 27,624 shares at $33.8369. After these transactions, the reporting entity held 1,498,921 shares directly.
The document clarifies that the reported prices are weighted averages from multiple trades and that Mr. Hoffman may be deemed an indirect beneficial owner of the shares held by Reprogrammed but disclaims ownership except for his pecuniary interest. Signatures for Reid Hoffman and Frank Huang (Manager of Reprogrammed Interchange LLC) appear with dates of 10/08/2025.
Positive
- None.
Negative
- None.
Insights
Insider sales were disclosed across multiple dates with remaining large direct holdings.
The sales reduce direct holdings from prior totals to 1,498,921 shares held by the reporting entity, indicating continued ownership while realizing liquidity. The filing uses standard disclosure language noting weighted average prices and multiple trade executions.
Key dependencies include whether additional scheduled sales exist and the reporting persons' continued roles; monitor any future Form 4 filings within several weeks for further reductions or changes in ownership.
Aggregate disclosed sales totaled 98,387 shares across two trading dates.
Those sales occurred at weighted average prices between $33.8369 and $37.7743, which may modestly affect float depending on daily volume. The filing does not state any 10b5-1 plan; instead it reports standard open-market transactions executed in multiple trades.
Watch trading volumes and subsequent Form 4 entries over the next 30 days to gauge whether these are isolated liquidity events or part of a larger, ongoing disposition.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 27,624 | $33.8369 | $935K |
| Sale | Common Stock | 17,760 | $36.0018 | $639K |
| Sale | Common Stock | 34,847 | $37.1213 | $1.29M |
| Sale | Common Stock | 18,156 | $37.7743 | $686K |
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $35.59 to $36.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein. This transaction was executed in multiple trades at prices ranging from $36.59 to $37.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $37.59 to $38.18 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. This transaction was executed in multiple trades at prices ranging from $33.70 to $34.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
